Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Renal Cell Carcinoma · Stage III Renal Cell Cancer AJCC v8 · Stage IV Renal Cell Cancer AJCC v8 · Unresectable Renal Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States

  • Kingman Regional Medical Center, Kingman, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Mark Waddle)
  • University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · 501-686-8274
    Contact: Principal Investigator (Sanjay Maraboyina)
  • PCR Oncology, Arroyo Grande, California, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Tower Cancer Research Foundation, Beverly Hills, California, United States

    Contact: Study coordinator (Site Public Contact) · towercancerresearch@toweroncology.com
    Contact: Principal Investigator (Leslie Ballas)
  • Mills-Peninsula Medical Center, Burlingame, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Christopher U. Jones)
  • City of Hope Comprehensive Cancer Center, Duarte, California, United States

  • UC San Diego Health System - Encinitas, Encinitas, California, United States

    Contact: Study coordinator (Site Public Contact) · 760-536-7700
    Contact: Principal Investigator (Tyler M. Seibert)
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Shera Feinstein)
  • UC San Diego Moores Cancer Center, La Jolla, California, United States

    Contact: Study coordinator (Site Public Contact) · cancercto@ucsd.edu · 858-822-5354
    Contact: Principal Investigator (Tyler M. Seibert)
  • Los Angeles General Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · uscnorrisinfo@med.usc.edu · 323-865-0451
    Contact: Principal Investigator (Lauren A. Lukas)
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Lauren A. Lukas)
  • Cedars-Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · Cancer.trial.info@cshs.org · 310-423-2133
    Contact: Principal Investigator (Leslie Ballas)
  • Memorial Medical Center, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Christopher U. Jones)
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Shera Feinstein)
  • Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Christopher U. Jones)
  • Sutter Roseville Medical Center, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Christopher U. Jones)
  • Sutter Medical Center Sacramento, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Christopher U. Jones)
  • UC San Diego Medical Center - Hillcrest, San Diego, California, United States

    Contact: Study coordinator (Site Public Contact) · rhabbaba@health.ucsd.edu
    Contact: Principal Investigator (Tyler M. Seibert)
  • UCSF Medical Center-Mission Bay, San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · cancertrials@ucsf.edu · 877-827-3222
    Contact: Principal Investigator (Steven N. Seyedin)
  • Pacific Central Coast Health Center-San Luis Obispo, San Luis Obispo, California, United States

  • Mills Health Center, San Mateo, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Christopher U. Jones)
  • Ridley-Tree Cancer Center, Santa Barbara, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Christopher U. Jones)
  • Sutter Pacific Medical Foundation, Santa Rosa, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org · 415-209-2683
    Contact: Principal Investigator (Christopher U. Jones)
  • UCHealth University of Colorado Hospital, Aurora, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 720-848-0650
    Contact: Principal Investigator (Corbin Eule)
  • UCHealth - Cherry Creek, Denver, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Corbin Eule)
  • Poudre Valley Hospital, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-297-6150
    Contact: Principal Investigator (Corbin Eule)
  • Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Corbin Eule)
  • UCHealth Greeley Hospital, Greeley, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Corbin Eule)
  • UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 720-848-0650
    Contact: Principal Investigator (Corbin Eule)
  • UCHealth Lone Tree Health Center, Lone Tree, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Corbin Eule)
  • Medical Center of the Rockies, Loveland, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-203-7083
    Contact: Principal Investigator (Corbin Eule)
  • Beebe Medical Center, Lewes, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • Beebe South Coastal Health Campus, Millville, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • Helen F Graham Cancer Center, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Medical Oncology Hematology Consultants PA, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Beebe Health Campus, Rehoboth Beach, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Mount Sinai Comprehensive Cancer Center at Aventura, Aventura, Florida, United States

    Contact: Study coordinator (Site Public Contact) · yenrique@msmc.com · 305-674-2625
    Contact: Principal Investigator (Debra L. Linzer)
  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States

    Contact: Study coordinator (Site Public Contact) · OHR@mhs.net · 954-265-1847
    Contact: Principal Investigator (Brian A. Pico)
  • Mayo Clinic in Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Mark Waddle)
  • Miami Cancer Institute, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 786-596-2000
    Contact: Principal Investigator (Adeel Kaiser)
  • Mount Sinai Medical Center, Miami Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · Yvonne.Enriquez@msmc.com · 305-674-2625
    Contact: Principal Investigator (Debra L. Linzer)
  • Memorial Hospital West, Pembroke Pines, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 954-265-4325
    Contact: Principal Investigator (Brian A. Pico)
  • Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · stephanie.couch@stjoeshealth.org · 734-712-3671
    Contact: Principal Investigator (Samir Narayan)
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · stephanie.couch@stjoeshealth.org · 734-712-3671
    Contact: Principal Investigator (Samir Narayan)
  • Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (Samir Narayan)
  • Alton Memorial Hospital, Alton, Illinois, United States

  • Centralia Oncology Clinic, Centralia, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancer@northwestern.edu · 312-695-1301
    Contact: Principal Investigator (Sean Sachdev)
  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Stanley L. Liauw)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Daniel H. Barnett)
  • Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Sean Sachdev)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Daniel H. Barnett)
  • Crossroads Cancer Center, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Sean Sachdev)
  • Northwestern Medicine Glenview Outpatient Center, Glenview, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (Sean Sachdev)
  • Northwestern Medicine Grayslake Outpatient Center, Grayslake, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (Sean Sachdev)
  • Ingalls Memorial Hospital, Harvey, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@ingalls.org · 708-915-4673
    Contact: Principal Investigator (James A. Wallace)
  • Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancertrials@northwestern.edu
    Contact: Principal Investigator (Sean Sachdev)
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Daniel H. Barnett)
  • UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Stanley L. Liauw)
  • Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • HSHS Saint Elizabeth's Hospital, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Oak Brook, Oak Brook, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (Sean Sachdev)
  • Northwestern Medicine Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (Sean Sachdev)
  • University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Stanley L. Liauw)
  • UW Health Carbone Cancer Center Rockford, Rockford, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · lkline@uwhealth.org · 779-696-9378
    Contact: Principal Investigator (Fahrettin Covut)
  • Memorial Hospital East, Shiloh, Illinois, United States

  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 217-545-7929
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-444-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Memorial Hospital, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · pallante.beth@mhsil.com · 217-528-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Daniel H. Barnett)
  • The Carle Foundation Hospital, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Daniel H. Barnett)
  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Sean Sachdev)
  • UChicago Medicine Northwest Indiana, Crown Point, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 855-702-8222
    Contact: Principal Investigator (Stanley L. Liauw)
  • Franciscan Health Indianapolis, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 317-528-7060
    Contact: Principal Investigator (Craig Schneider)
  • Franciscan Health Mooresville, Mooresville, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 317-834-3603
    Contact: Principal Investigator (Craig Schneider)
  • Mary Greeley Medical Center, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • McFarland Clinic - Ames, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · ksoder@mcfarlandclinic.com · 515-239-4734
    Contact: Principal Investigator (Joseph J. Merchant)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@marybird.com · 225-215-1353
    Contact: Principal Investigator (Victor T. Lin)
  • Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@marybird.com · 225-215-1353
    Contact: Principal Investigator (Victor T. Lin)
  • Mary Bird Perkins Cancer Center - Metairie, Metairie, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · 504-584-6990
    Contact: Principal Investigator (Victor T. Lin)
  • East Jefferson General Hospital, Metairie, Louisiana, United States

  • LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie, Louisiana, United States

  • Louisiana State University Health Science Center, New Orleans, Louisiana, United States

  • University Medical Center New Orleans, New Orleans, Louisiana, United States

  • Touro Infirmary, New Orleans, Louisiana, United States

  • MaineHealth Coastal Cancer Treatment Center, Bath, Maine, United States

  • MaineHealth Maine Medical Center - Biddeford, Biddeford, Maine, United States

  • MaineHealth Maine Medical Center - Portland, Portland, Maine, United States

  • MaineHealth Cancer Care and IV Therapy - Sanford, Sanford, Maine, United States

  • MaineHealth Cancer Care Center of York County, Sanford, Maine, United States

  • MaineHealth Maine Medical Center- Scarborough, Scarborough, Maine, United States

  • MaineHealth Cancer Care and IV Therapy - South Portland, South Portland, Maine, United States

  • University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States

  • Central Maryland Radiation Oncology in Howard County, Columbia, Maryland, United States

  • UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie, Maryland, United States

  • Beverly Hospital, Beverly, Massachusetts, United States

  • Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-726-5130
    Contact: Principal Investigator (Sophia C. Kamran)
  • Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 617-724-5200
    Contact: Principal Investigator (Bradley A. McGregor)
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-442-3324
    Contact: Principal Investigator (Bradley A. McGregor)
  • Lahey Hospital and Medical Center, Burlington, Massachusetts, United States

  • Addison Gilbert Hospital, Gloucester, Massachusetts, United States

  • Lahey Clinic Peabody, Peabody, Massachusetts, United States

  • Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care, Winchester, Massachusetts, United States

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CancerAnswerLine@med.umich.edu · 800-865-1125
    Contact: Principal Investigator (William C. Jackson)
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • Trinity Health Medical Center - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • Trinity Health Medical Center - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • Corewell Health Dearborn Hospital, Dearborn, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (Daniel J. Krauss)
  • Corewell Health Farmington Hills Hospital, Farmington Hills, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (Daniel J. Krauss)
  • University of Michigan Health - Sparrow Lansing, Lansing, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · harsha.trivedi@umhsparrow.org · 517-364-3712
    Contact: Principal Investigator (Samir Narayan)
  • Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (Daniel J. Krauss)
  • Corewell Health Beaumont Troy Hospital, Troy, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (Daniel J. Krauss)
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Samir Narayan)
  • Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 218-333-5000
    Contact: Principal Investigator (Daniel Almquist)
  • Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Minnesota Oncology Hematology PA-Chaska, Chaska, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Charles Shideman)
  • Essentia Health - Deer River Clinic, Deer River, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Cancer Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Miller-Dwan Hospital, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Fairview Southdale Hospital, Edina, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Charles Shideman)
  • Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Charles Shideman)
  • Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Charles Shideman)
  • Hennepin County Medical Center, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Charles Shideman)
  • University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 612-624-2620
    Contact: Principal Investigator (Ian J. Okazaki)
  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Mark Waddle)
  • Regions Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Charles Shideman)
  • Essentia Health Sandstone, Sandstone, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Saint Francis Regional Medical Center, Shakopee, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Charles Shideman)
  • Lakeview Hospital, Stillwater, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Charles Shideman)
  • Essentia Health Virginia Clinic, Virginia, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Ridgeview Medical Center, Waconia, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Charles Shideman)
  • Saint Francis Medical Center, Cape Girardeau, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · sfmc@sfmc.net · 573-334-2230
    Contact: Principal Investigator (Bryan A. Faller)
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States

  • MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 573-882-7440
    Contact: Principal Investigator (Gregory B. Biedermann)
  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

  • Mercy Hospital Springfield, Springfield, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 417-269-4520
    Contact: Principal Investigator (Jay W. Carlson)
  • Washington University School of Medicine, St Louis, Missouri, United States

  • Mercy Hospital South, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · Danielle.Werle@mercy.net · 314-525-6042
    Contact: Principal Investigator (Jay W. Carlson)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

  • Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States

  • Mercy Hospital Saint Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-251-7066
    Contact: Principal Investigator (Jay W. Carlson)
  • Nebraska Medicine-Bellevue, Bellevue, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Harshraj Leuva)
  • Nebraska Medicine-Village Pointe, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-559-5600
    Contact: Principal Investigator (Harshraj Leuva)
  • University of Nebraska Medical Center, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Harshraj Leuva)
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Daniel Gorovets)
  • Cooper Hospital University Medical Center, Camden, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 856-325-6757
    Contact: Principal Investigator (Gary Eastwick)
  • Monmouth Medical Center Southern Campus, Lakewood, New Jersey, United States

  • Monmouth Medical Center, Long Branch, New Jersey, United States

  • Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Daniel Gorovets)
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Daniel Gorovets)
  • Cooper CyberKnife Center, Mount Laurel, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · research-cancer@cooperhealth.edu · 855-632-2667
    Contact: Principal Investigator (Gary Eastwick)
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

  • Rutgers New Jersey Medical School, Newark, New Jersey, United States

  • Community Medical Center, Toms River, New Jersey, United States

  • Lovelace Medical Center-Saint Joseph Square, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · ZPollock@salud.unm.edu · 505-272-0530
    Contact: Principal Investigator (Malcolm H. Purdy)
  • Lovelace Radiation Oncology, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · AYost@nmcca.org · 505-272-0530
    Contact: Principal Investigator (Malcolm H. Purdy)
  • Northwell Health Imbert Cancer Center, Bay Shore, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Clary Evans)
  • Memorial Sloan Kettering Commack, Commack, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Daniel Gorovets)
  • Glens Falls Hospital, Glens Falls, New York, United States

    Contact: Study coordinator (Site Public Contact) · 518-926-6700
    Contact: Principal Investigator (Nataniel H. Lester-Coll)
  • Northwell Health Cancer Institute at Huntington, Greenlawn, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Clary Evans)
  • Memorial Sloan Kettering Westchester, Harrison, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Daniel Gorovets)
  • Northwell Health/Center for Advanced Medicine, Lake Success, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Clary Evans)
  • Northern Westchester Hospital, Mount Kisco, New York, United States

    Contact: Study coordinator (Site Public Contact) · AMellor@northwell.edu · 914-666-1366
    Contact: Principal Investigator (Clary Evans)
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@nyulangone.org
    Contact: Principal Investigator (Anand Mahadevan)
  • Manhattan Eye Ear and Throat Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-434-4460
    Contact: Principal Investigator (Clary Evans)
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Daniel Gorovets)
  • Lenox Hill Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Clary Evans)
  • Phelps Memorial Hospital Center, Sleepy Hollow, New York, United States

    Contact: Study coordinator (Site Public Contact) · 914-366-1600
    Contact: Principal Investigator (Clary Evans)
  • Stony Brook University Medical Center, Stony Brook, New York, United States

  • Memorial Sloan Kettering Nassau, Uniondale, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Daniel Gorovets)
  • Duke Cancer Center Cary, Cary, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · NCTNStudyTeam@dm.duke.edu
    Contact: Principal Investigator (Ryan E. Fecteau)
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@med.unc.edu · 877-668-0683
    Contact: Principal Investigator (Tracy L. Rose)
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Claud M. Grigg)
  • Atrium Health Pineville/LCI-Pineville, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 980-442-2000
    Contact: Principal Investigator (Claud M. Grigg)
  • Atrium Health University City/LCI-University, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Claud M. Grigg)
  • Levine Cancer Institute-Ballantyne, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Claud M. Grigg)
  • Wake Forest University at Clemmons, Clemmons, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-716-9259
    Contact: Principal Investigator (Michael McCormack)
  • Atrium Health Cabarrus/LCI-Concord, Concord, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Claud M. Grigg)
  • Duke University Medical Center, Durham, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-275-3853
    Contact: Principal Investigator (Ryan E. Fecteau)
  • Levine Cancer Institute-Gaston, Gastonia, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Claud M. Grigg)
  • Hayworth Cancer Center, High Point, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 336-802-2500
    Contact: Principal Investigator (Michael McCormack)
  • Atrium Health Union/LCI-Union, Monroe, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 980-442-2000
    Contact: Principal Investigator (Claud M. Grigg)
  • Duke Cancer Center Raleigh, Raleigh, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · NCTNStudyTeam@dm.duke.edu
    Contact: Principal Investigator (Ryan E. Fecteau)
  • Wake Forest Baptist Health - Wilkes Medical Center, Wilkesboro, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-716-9253
    Contact: Principal Investigator (Michael McCormack)
  • Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 336-713-6771
    Contact: Principal Investigator (Michael McCormack)
  • Sanford Bismarck Medical Center, Bismarck, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Broadway Medical Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-234-6161
    Contact: Principal Investigator (Daniel Almquist)
  • UH Seidman Cancer Center at UH Avon Health Center, Avon, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 800-641-2422
    Contact: Principal Investigator (Pedro Barata)
  • UHHS-Chagrin Highlands Medical Center, Beachwood, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Pedro Barata)
  • Dayton Physicians LLC-Miami Valley South, Centerville, Ohio, United States

  • Miami Valley Hospital South, Centerville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · cancer@uchealth.com · 513-584-7698
    Contact: Principal Investigator (Timothy D. Struve)
  • Case Western Reserve University, Cleveland, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Pedro Barata)
  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (Shang-Jui Wang)
  • Miami Valley Hospital, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Premier Blood and Cancer Center, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-276-8320
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Dayton Physician LLC - Englewood, Dayton, Ohio, United States

  • Miami Valley Hospital North, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Dayton Physicians LLC-Atrium, Franklin, Ohio, United States

  • Miami Valley Cancer Care and Infusion, Greenville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-569-7515
    Contact: Principal Investigator (Tarek M. Sabagh)
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Pedro Barata)
  • University Hospitals Parma Medical Center, Parma, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Pedro Barata)
  • University Hospitals Portage Medical Center, Ravenna, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Pedro Barata)
  • Upper Valley Medical Center, Troy, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · cancer@uchealth.com · 513-584-7698
    Contact: Principal Investigator (Timothy D. Struve)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Tyler Gunter)
  • Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · 918-505-3200
    Contact: Principal Investigator (Mark B. Jennings)
  • Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Samir Narayan)
  • UPMC-Heritage Valley Health System Beaver, Beaver, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Adam Olson)
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Samir Narayan)
  • Carlisle Regional Cancer Center, Carlisle, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Adam Olson)
  • Christiana Care Health System-Concord Health Center, Chadds Ford, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Geisinger Medical Center, Danville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Fiori Alite)
  • UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Adam Olson)
  • Saint Vincent Hospital, Erie, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 814-452-5000
    Contact: Principal Investigator (Alexander Helfand)
  • UPMC Cancer Center at UPMC Horizon, Farrell, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Adam Olson)
  • UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 724-838-1900
    Contact: Principal Investigator (Adam Olson)
  • UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · klitchfield@PINNACLEHEALTH.org · 717-724-6765
    Contact: Principal Investigator (Adam Olson)
  • Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-459-2901
    Contact: Principal Investigator (Fiori Alite)
  • Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · CTO@hmc.psu.edu · 717-531-3779
    Contact: Principal Investigator (Joseph A. Miccio)
  • IRMC Cancer Center, Indiana, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Adam Olson)
  • Jefferson Hospital, Jefferson Hills, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ddefazio@wpahs.org · 412-359-3043
    Contact: Principal Investigator (Alexander Helfand)
  • Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-374-8555
    Contact: Principal Investigator (Fiori Alite)
  • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Adam Olson)
  • Forbes Hospital, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-858-7746
    Contact: Principal Investigator (Alexander Helfand)
  • UPMC Cancer Center - Monroeville, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Adam Olson)
  • UPMC Hillman Cancer Center - Monroeville, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Adam Olson)
  • UPMC Hillman Cancer Center - New Castle, New Castle, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Adam Olson)
  • Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 877-284-2000
    Contact: Principal Investigator (Alexander Helfand)
  • UPMC-Magee Womens Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-2811
    Contact: Principal Investigator (Adam Olson)
  • UPMC-Saint Margaret, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-784-4900
    Contact: Principal Investigator (Adam Olson)
  • West Penn Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-578-5000
    Contact: Principal Investigator (Alexander Helfand)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Adam Olson)
  • UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-621-2334
    Contact: Principal Investigator (Adam Olson)
  • UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-367-6454
    Contact: Principal Investigator (Adam Olson)
  • UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-502-3920
    Contact: Principal Investigator (Adam Olson)
  • Geisinger Cancer Services-Pottsville, Pottsville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 800-275-6401
    Contact: Principal Investigator (Fiori Alite)
  • Community Medical Center, Scranton, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-703-4768
    Contact: Principal Investigator (Fiori Alite)
  • UPMC Cancer Center at UPMC Northwest, Seneca, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 814-676-7900
    Contact: Principal Investigator (Adam Olson)
  • UPMC Cancer Center-Washington, Washington, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Adam Olson)
  • UPMC Washington Hospital Radiation Oncology, Washington, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · cancer@washingtonhospital.org · 724-223-3788
    Contact: Principal Investigator (Adam Olson)
  • Reading Hospital, West Reading, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 610-988-9323
    Contact: Principal Investigator (Michael L. Haas)
  • Wexford Health and Wellness Pavilion, Wexford, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Dawnmarie.DeFazio@ahn.org
    Contact: Principal Investigator (Alexander Helfand)
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Fiori Alite)
  • Divine Providence Hospital, Williamsport, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Adam Olson)
  • UPMC Memorial, York, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 717-724-6760
    Contact: Principal Investigator (Adam Olson)
  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · hcc-clinical-trials@musc.edu · 843-792-9321
    Contact: Principal Investigator (Harriet B. Eldredge-Hindy)
  • Self Regional Healthcare, Greenwood, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · nmcgaha@selfregional.org · 864-725-4771
    Contact: Principal Investigator (Harriet B. Eldredge-Hindy)
  • Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicTrialsSF@sanfordhealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsSF@SanfordHealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Parkland Memorial Hospital, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-590-5582
    Contact: Principal Investigator (Raquibul Hannan)
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@utsouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Raquibul Hannan)
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Raquibul Hannan)
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Raquibul Hannan)
  • UT Southwestern Clinical Center at Richardson/Plano, Richardson, Texas, United States

    Contact: Study coordinator (Site Public Contact) · Suzanne.cole@utsouthwestern.edu · 972-669-7044
    Contact: Principal Investigator (Raquibul Hannan)
  • Scott and White Memorial Hospital, Temple, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 254-724-5407
    Contact: Principal Investigator (Lucas Wong)
  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · 802-225-5400
    Contact: Principal Investigator (Nataniel H. Lester-Coll)
  • University of Vermont Medical Center, Burlington, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · rpo@uvm.edu · 802-656-4101
    Contact: Principal Investigator (Nataniel H. Lester-Coll)
  • University of Vermont and State Agricultural College, Burlington, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · rpo@uvm.edu · 802-656-8990
    Contact: Principal Investigator (Nataniel H. Lester-Coll)
  • Inova Alexandria Hospital, Alexandria, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.VanBebber@inova.org · 703-776-2580
    Contact: Principal Investigator (Daniel W. Kim)
  • Inova Schar Cancer Institute, Fairfax, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.VanBebber@inova.org · 703-720-5210
    Contact: Principal Investigator (Daniel W. Kim)
  • Inova Fair Oaks Hospital, Fairfax, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.VanBebber@inova.org · 703-720-5210
    Contact: Principal Investigator (Daniel W. Kim)
  • Bon Secours Saint Francis Medical Center, Midlothian, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Cancer Institute at Reynolds Crossing, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Anne_caramella@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Virginia Mason Medical Center, Seattle, Washington, United States

    Contact: Study coordinator (Site Public Contact) · cancerresearch@virginiamason.org · 206-287-6275
    Contact: Principal Investigator (Huong T. Pham)
  • West Virginia University Charleston Division, Charleston, West Virginia, United States

  • Edwards Comprehensive Cancer Center, Huntington, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Christina.Cole@chhi.org · 304-399-6566
    Contact: Principal Investigator (Toni O. Pacioles)
  • Langlade Hospital and Cancer Center, Antigo, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Juli.Alford@aspirus.org · 715-623-9869
    Contact: Principal Investigator (Andrew J. Huang)
  • Duluth Clinic Ashland, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Northwest Wisconsin Cancer Center, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Bevan Ly)
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Essentia Health-Hayward Clinic, Hayward, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · cancerctr@gundersenhealth.org · 608-775-2385
    Contact: Principal Investigator (Collin D. Driscoll)
  • Marshfield Medical Center - Ladysmith, Ladysmith, Wisconsin, United States

  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Hamid Emamekhoo)
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Hamid Emamekhoo)
  • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Bevan Ly)
  • Froedtert Menomonee Falls Hospital, Menomonee Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-257-5100
    Contact: Principal Investigator (William A. Hall)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-3666
    Contact: Principal Investigator (William A. Hall)
  • Marshfield Medical Center - Minocqua, Minocqua, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Bevan Ly)
  • ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · research.institute@phci.org
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Marshfield Medical Center - Neillsville, Neillsville, Wisconsin, United States

  • Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Charles Shideman)
  • Drexel Town Square Health Center, Oak Creek, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (William A. Hall)
  • ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7878
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Aspirus Cancer Care - James Beck Cancer Center, Rhinelander, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Beth.Knetter@aspirus.org · 715-847-2353
    Contact: Principal Investigator (Andrew J. Huang)
  • Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Bevan Ly)
  • Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Essentia Health-Spooner Clinic, Spooner, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Aspirus Cancer Care - Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Beth.Knetter@aspirus.org · 715-847-2353
    Contact: Principal Investigator (Andrew J. Huang)
  • Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Bevan Ly)
  • Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Essentia Health Saint Mary's Hospital - Superior, Superior, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 701-364-6272
    Contact: Principal Investigator (Bret E. Friday)
  • UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Chanda.miller@phci.org · 262-928-5539
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Aspirus Regional Cancer Center, Wausau, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 877-405-6866
    Contact: Principal Investigator (Andrew J. Huang)
  • Froedtert West Bend Hospital/Kraemer Cancer Center, West Bend, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (William A. Hall)
  • Marshfield Medical Center - Weston, Weston, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Bevan Ly)
  • Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 715-422-7718
    Contact: Principal Investigator (Andrew J. Huang)
  • Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin, United States

  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

    Contact: Study coordinator (Site Public Contact) · 61 3 9656 1521
    Contact: Principal Investigator (Shankar Siva)
  • University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada

  • CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ), Québec, Quebec, Canada

    Contact: Study coordinator (Site Public Contact) · rechclinique@crchuq.ulaval.ca
    Contact: Principal Investigator (Isabelle Thibault)
  • Beacon Hospital, Dublin, Co Dublin, Ireland

    Contact: Study coordinator (Site Public Contact) · 353 1 2936691
    Contact: Principal Investigator (Alina M. Mihai)
  • Saint Lukes Hospital, Dublin, Co Dublin, Ireland

    Contact: Study coordinator (Site Public Contact) · 353 1 4065000
    Contact: Principal Investigator (Pierre Thirion)
Study leads
  • William A Hall

    Principal Investigator

    NRG Oncology